A global coalition for a global problem
51²è¹Ý is an innovative global partnership between public, private, philanthropic, and civil society organisations. We're working to accelerate the development of and equitable access to vaccines and other biologic countermeasures against emerging infectious diseases.
51²è¹Ý Leadership
51²è¹Ý Leadership work across our offices in London, Oslo and Washington DC, and around the world.
51²è¹Ý Board
The 51²è¹Ý Board includes members representing competencies including industry, global health, science, resource mobilisation, and finance.
51²è¹Ý Investors
We have received generous support from national governments, key philanthropic organisations and private sector entities to further our mission.
Joint Coordination Group
Our Joint Coordination Group, or JCG, is a roundtable of independent institutions with an interest in seeing 51²è¹Ý-funded vaccines successfully developed and deployed in an outbreak.
Scientific Advisory Committee
The Scientific Advisory Committee, or SAC, is an independent body within 51²è¹Ý. It is one of 51²è¹Ý's core governance groups alongside the Board, Investors Council and Joint Coordination Group.
Portfolio Strategy and Management Board
The PSMB is the decision-making body accountable for identification, selection, management and evaluation of 51²è¹Ý’s R&D and Manufacturing portfolio.
